Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

This study demonstrates that combining epigenetic and genomic biomarkers across minimally invasive sampling methods can accurately distinguish HGD/esophageal adenocarcinoma from nondysplastic Barrett's esophagus, offering promising, less invasive strategies to improve BE surveillance and enable endoscopic therapy for esophageal adenocarcinoma prevention and treatment.

Authors

Institutions

Publication Details

Journal
Cancer Prevention Research
Published
2025-10-07
DOI
https://doi.org/10.1158/1940-6207.capr-25-0215
Citations
2
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
4.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

Herbert C. Wolfsen, Arvind J. Trindade, Prasad G. Iyer, William R. Taylor et al.
2 citations
Cancer Prevention Research
Esophageal Cancer Research and Treatment
4.01
article

Discovery and Validation of Molecular Biomarkers for Differentiation of Nondysplastic Barrett’s Esophagus from High-grade Dysplasia and Esophageal Adenocarcinoma

Herbert C. Wolfsen, Arvind J. Trindade, Prasad G. Iyer, William R. Taylor, Panwen Wang, John B. Kisiel, Allon Kahn, Melissa Passe, Patrick H. Foote, Francisco C. Ramirez, Caroline L. Matchett, Douglas W. Mahoney, Jeanette E. Eckel‐Passow, Seth W. Slettedahl, Calise K. Berger, Vani J. Konda, Don C. Codipilly, Zhifu Sun, Swathi Eluri, Ramona Lansing, Cadman L. Leggett, Collin E. Chalmers, Caryn E. Anderson
article en
2 citations

Abstract

This study demonstrates that combining epigenetic and genomic biomarkers across minimally invasive sampling methods can accurately distinguish HGD/esophageal adenocarcinoma from nondysplastic Barrett's esophagus, offering promising, less invasive strategies to improve BE surveillance and enable endoscopic therapy for esophageal adenocarcinoma prevention and treatment.

Cancer Prevention ResearchVol. 19(1)
Rutgers, The State University of New Jersey (US), Mayo Clinic (US), Baylor University (US), Jacksonville College (US), WinnMed (US), Mayo Clinic in Arizona (US), Mayo Clinic Hospital (US), Mayo Clinic in Florida (US), Baylor Scott & White Health (US)
National Institutes of Health
Openalex Percentile: Top 6%
Esophageal Cancer Research and Treatment
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.